Metabolomic distinction and insights into the pathogenesis of human primary dilated cardiomyopathy
Version of Record online: 14 DEC 2010
© 2010 The Authors. European Journal of Clinical Investigation © 2010 Stichting European Society for Clinical Investigation Journal Foundation
European Journal of Clinical Investigation
Volume 41, Issue 5, pages 527–538, May 2011
How to Cite
Alexander, D., Lombardi, R., Rodriguez, G., Mitchell, M. M. and Marian, A. J. (2011), Metabolomic distinction and insights into the pathogenesis of human primary dilated cardiomyopathy. European Journal of Clinical Investigation, 41: 527–538. doi: 10.1111/j.1365-2362.2010.02441.x
- Issue online: 6 APR 2011
- Version of Record online: 14 DEC 2010
- Received 12 August 2010; accepted 2 November 2010
Table S1. Compound inclusion summary, broken down by Mass Spectroscopy.
Table S2. Summary of analytical and study variation.
|ECI_2441_sm_OnlineSupplementaryTables1-2.docx||45K||Supporting info item|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.